期刊名称：SCHIZOPHRENIA BULLETIN
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Schizophrenia Bulletin seeks to review recent developments and empirically based hypotheses regarding the etiology and treatment of schizophrenia.
We view the field as broad and deep, and will publish new knowledge ranging from the molecular basis to social and cultural factors. We will give new emphasis to translational reports which simultaneously highlight basic neurobiological mechanisms and clinical manifestations. Much of the Bulletin content will be invited reviews and manuscripts organized as a theme by special guest editors. Also, the Bulletin will carry unsolicited manuscripts of high quality that report original data related to theme issues or where the Bulletin can provide a special venue for a major study.
Instructions to Authors
Information for Authors
Schizophrenia Bulletin is an international peer-reviewed journal that publishes original reports and reviews of clinical and experimental research relating to all aspects of schizophrenia. Each issue is based on one or more themes with articles about recent advances in the clinical and basic scientific aspects of that area. A guest editor will be responsible for planning and organizing the theme content and will typically invite contributions from leaders in the field. Themes for future issues will be published in advance. Schizophrenia Bulletin will consider unsolicited full-length manuscripts relating to any aspect of a future theme issue provided they have scientific merit and represent an important advance in knowledge. The Bulletin will also regularly publish an At Issue section containing unsolicited articles on theory or controversial topics including issues in ethics. Historical perspectives from patients and their families are also welcome.
EDITORIAL POLICIES
Manuscripts must be written in English and are accepted for consideration with an explicit understanding that the material has not been previously published in whole or substantial part and is not currently under consideration for publication by any other journal. All matters relating to the editorial policies of Schizophrenia Bulletin should be addressed in writing to Prof. William Carpenter, M.D., Editor-in Chief, Schizophrenia Bulletin Editorial Office, Maryland Psychiatric Research Center, PO Box 21247, Baltimore, MD 21228, USA. Manuscripts should be submitted at www.schizophreniabulletin.oxfordjournals.org as instructed below.
Copyright
Schizophrenia Bulletin does not require authors to transfer copyright of their submitted material. Rather, it is a condition of publication in the journal that authors grant an exclusive license to the Maryland Psychiatric Research Center and Oxford University Press. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning the license, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and that the Maryland Psychiatric Research Center and Oxford University Press are notified in writing and in advance.
Informed Consent and Ethics Committee Approval
Manuscripts reporting experiments on patients or healthy volunteers must record the fact that the subjects' consent was obtained and include a statement that the research was approved by the responsible ethical committee of the institution (e.g., an institutional review board) and was consistent with the principles outlined in an internationally recognized standard for the ethical conduct of human research. Consent must be also recorded when photographs of patients are shown or other details given that could lead to the identification of the individuals. Authors may be required to provide tangible proof that the necessary permissions and consents have been obtained from study participants.
Laboratory Animals
Manuscripts reporting the results of experiments involving laboratory animals must be contain a statement indicating that the procedures used were in accordance with the guidelines published in the Institute of Laboratory Animals Resources Commission on Life Sciences' 1996 Guide for the Care and Use of Laboratory Animals (Washington, DC: National Academic Press; http://www.nap.edu/readingroom/books/labrats) or a similar internationally recognized standard. The species, sex, source, and genetic background of the animals as well as a detailed description of the experimental procedures, including any anesthetics and/or analgesics, must be provided in the Methods section of the manuscript.
Manuscripts containing data from human or animal experimentation may be rejected if the ethical aspects are open to question. The corresponding author will be held responsible for false statements or for failure to meet the aforementioned requirements.
Conflict of Interest
At the point of submission, Schizophrenia Bulletin's policy requires that each author reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?
As an integral part of the online submission process, Corresponding authors are required to confirm whether they or their co-authors have any conflicts of interest to declare, and to provide details of these. If the Corresponding author is unable to confirm this information on behalf of all co-authors, the authors in question will then be required to submit a completed Conflict of Interest form to the Editorial Office. It is the Corresponding author’s responsibility to ensure that all authors adhere to this policy.
If the manuscript is published, Conflict of Interest information will be communicated in a statement in the published
Funding
Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgements' section.
The following rules should be followed:
The sentence should begin: ‘This work was supported by …’
The full official funding agency name should be given, i.e. ‘National Institutes of Health? not ‘NIH?(full RIN-approved list of UK funding agencies) Grant numbers should be given in brackets as follows: ‘[grant number xxxx]?BR>Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers xxxx, yyyy]?BR>Agencies should be separated by a semi-colon (plus ‘and?before the last funding agency)
Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'.
An example is given here: ‘This work was supported by the National Institutes of Health [AA123456 to C.S., BB765432 to M.H.]; and the Alcohol & Education Research Council [hfygr667789].
Author Self-Archiving/Public Access Policy from May 2005
For information about this journal's policy, please visit our Author Self-Archiving policy page.
MANUSCRIPT PREPARATION
All manuscripts are submitted and reviewed via Manuscript Central, accessible through Schizophrenia Bulletin's website at http://www.schizophreniabulletin.oxfordjournals.org. New authors should create an account prior to submitting a manuscript for consideration.
Manuscripts submitted to Schizophrenia Bulletin should be prepared following the American Medical Association Manual of Style, 10th edition. The manuscript text (including tables) should be prepared using a word processing program and saved as an .rtf or .doc file. Other file formats will not be accepted. Figures must be saved as individual .tif files and should be numbered consecutively (i.e., Figure 1.tif, Figure 2.tif, etc.). The text must be double-spaced throughout and should consist of the sections described below. Please note: This journal does not accept Microsoft Word 2007 documents at this time. Please use Word's "Save As" option to save your document as an older (.doc) file type.
Title Page
This page should consist of (i) the complete title of the manuscript, (ii) a running title not to exceed 50 characters including spaces, (iii) the full name of each author and the authors' institutional affiliations, (iv) name, complete address, telephone, fax, and e-mail address of the corresponding author, and (v) separate word counts of the abstract and text body.
Abstract
Provide a summary of no more than 250 words describing why and how the study, analysis, or review was done, a summary of the essential results, and what the authors have concluded from the data. The abstract should not contain unexplained abbreviations. Up to six key words that do not appear as part of the title should be provided at the end of the abstract.
Main Text
Unsolicited original manuscripts reporting novel experimental findings should be comprised of these sections, in this order: Abstract, Introduction, Methods, Results, Discussion, Acknowledgments, References, and Figure Legends. Review articles must contain an abstract; however, the body of the text can be organized in a less structured format. Authors of review articles are encouraged to use section headers to improve the readability of their manuscript.
Number pages consecutively beginning with the title page. Spelling should conform to that used in Merriam-Webster's Collegiate Dictionary, eleventh edition. Clinical laboratory data may be expressed in conventional rather than Système International (SI) units.
Acknowledgments
These should be as brief as possible but include the names of sources of logistical support.
References
Each reference should be cited in consecutive numerical order using superscript arabic numerals, and reference style should follow the recommendations in the American Medical Association Manual of Style, 10th edition, with one exception: in the reference list, the name of all authors should be given unless there are more than 6, in which case the names of the first 3 authors are used, followed by "et al."
Book: Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York, NY: Thieme Medical Publishers; 1998.
Book chapter: Goldberg TE, David A, Gold JM. Neurocognitive deficits in schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. Oxford, England: Blackwell Science; 2003:168-184.
Journal article: Thaker GK, Carpenter WT. Advances in schizophrenia. Nat Med 2001;7:667-671.
Journal article with more than 6 authors: Egan MF, Straub RE, Goldberg TE, et al. Variation in GRM3 affects cognition, prefrontal gluatamate, and risk for schizophrenia. Proc Natl Acad Sci USA 2004;101:12604-12609.
Article published on Advance Access only: Gilad, Y. and Lancet, D. March 5, 2003. Population Differences in the Human Functional Olfactory Repertoire. Mol Biol Evol doi:10.1093/molbev/msg013.
Article first published on Advance Access: Gilad, Y. and Lancet, D. 2003. Population Differences in the Human Functional Olfactory Repertoire Mol Biol Evol 2003;20:307-314. First published on March 5, 2003, doi:10.1093/molbev/msg013.
Journal names should be abbreviated in accordance with Index Medicus (www.nlm.nih.gov/tsd/serials/lji.html).
Manuscripts in which the references do not follow this format will be returned for retyping. References to meeting abstracts, material not yet accepted for publication, or personal communications are not acceptable as listed references and instead should be listed parenthetically in the text. It is the authors' responsibility for obtaining the necessary permissions from colleagues to include their work as a personal communication.
Note: In the online version of Schizophrenia Bulletin there are automatic links from the reference section of each article to cited articles in Medline. This is a useful feature for readers, but is only possible if the references are accurate. It is the responsibility of the author to ensure the accuracy of the references in the submitted article. Downloading references directly from Medline is highly recommended.
Figures and Tables
Figures and tables must be referred to using arabic numbers in order of their appearance in the text (e.g., Figure 1, Figure 2, Table 1, Table 2, etc.).
Tables should be created with the table function of a word processing program; spreadsheets are not acceptable. Include only essential data, and format the table in a manner in which it should appear in the text. Each table must fit on a single manuscript page and have a short title that is self-explanatory without reference to the text. Footnotes can be used to explain any symbols or abbreviations appearing in the table. Do not duplicate data in tables and figures.
Please be aware that the figure requirements for initial online submission (peer review) and for reproduction in the journal are different. Initially, it is preferred to embed your figures within the word processing file or upload them separately as low-resolution images (.jpg, .tif, or .gif files). However, upon submission of a revised manuscript, you will be required to supply high-resolution .tif files for reproduction in the journal (1200 d.p.i. for line drawings and 300 d.p.i. for color and half-tone artwork). It is advisable to create high-resolution images first as these can be easily converted into low-resolution images for online submission. Figure legends should be typed separately from the figures in the main text document. Additional information on preparing your figures for publication can be located at http://cpc.cadmus.com/da.
Wherever possible figures should be submitted in their desired final size, to fit the width of a single (88 mm) or at most a double (180 mm) column width. All letters and numerals appearing in a particular figure should be of the same size and in proportion to the overall dimensions of the drawing. Letter labels used in figures should be in upper case in both the figure and the legend. The journal reserves the right to reduce the size of illustrative material.
Color illustrations are accepted, but the authors will be required to contribute $600 per figure to the cost of their reproduction unless a waiver is obtained from the editorial office. If you ticked the color charge approval box in Manuscript Central, the online submission site for the journal, you will incur color figure charges. Orders from the UK will be subject to a 17.5% VAT charge. For orders from elsewhere in the EU you or your institution should account for VAT by way of a reverse charge. Please provide us with your or your institution’s VAT number.Illustrations for which color is not essential can be reproduced as black and white images in the print journal and, additionally, in color as online supplementary material. This option is not subject to color charges. Authors should indicate clearly that they would like to take up this option in the covering letter. The availability of additional color images as supplementary material should be mentioned where relevant in the main text of the manuscript. Instructions on how to submit color figures as supplementary material can be viewed here.
Each figure should have a separate legend that clearly identifies all symbols and abbreviations used. The legend should be concise and self-explanatory and should contain enough information to be understood without reference to the text.
Note: All tables and figures reproduced from a previously published manuscript must cite the original source (in the figure legend or table footnote) and be accompanied by a letter of permission from the publisher of record or the copyright owner.
Supplementary Material
Supporting material that is not essential for inclusion in the full text of the manuscript, but would nevertheless benefit the reader, can be made available by the publisher as online-only content, linked to the online manuscript. The material should not be essential to understanding the conclusions of the paper, but should contain data that is additional or complementary and directly relevant to the article content. Such information might include more detailed methods, extended data sets/data analysis, or additional figures (including color). It is standard practice for appendices to be made available online-only as supplementary material. All text and figures must be provided in separate files from the manuscript files labeled as supplementary material in suitable electronic formats (instructions for the preparation of supplementary material can be viewed here).
All material to be considered as supplementary material must be submitted at the same time as the main manuscript for peer review. It cannot be altered or replaced after the paper has been accepted for publication. Please indicate clearly the material intended as supplementary material upon submission. Also ensure that the supplementary material is referred to in the main manuscript where necessary.
Proofs
Page proofs will be sent to the corresponding author by e-mail as an Acrobat PDF file. The software needed to view this type of file can be downloaded at no charge from www.adobe.com/products/acrobat/readstep2.html. Please check text, tables, legends, and references carefully. Proofs must be returned within three days of receipt. The editors and publisher reserve the right to proceed with publication if this period is exceeded. Only typographical errors can be corrected at this stage; substantial changes to the text will not be accepted.
Reprints
The corresponding author will be provided with electronic offprints of their article at no charge. Paper copies may be ordered at the prices quoted on the order form that will accompany the article proofs. Orders from the UK will be subject to a 17.5% VAT charge. For orders from elsewhere in the EU you or your institution should account for VAT by way of a reverse charge. Please provide us with your or your institution’s VAT number.
Announcements
Announcements of future meetings, congresses, courses, awards, or other events that are likely to be of interest to the readers of Schizophrenia Bulletin may be submitted to the editorial office for consideration for publication in a future issue. Please provide a brief summary of the nature of the event and the name and e-mail address of a contact person.
OPEN ACCESS OPTION FOR AUTHORS
Starting in July 2004, Schizophrenia Bulletin authors have the option, at an additional charge, to make their paper freely available online immediately upon publication, under the Oxford Open initiative. After your manuscript is accepted, as part of the mandatory license form required of all corresponding authors, you will be asked to indicate whether or not you wish to pay to have your paper made freely available immediately. If you do not select the Open Access option, your paper will be published with standard subscription-based access and you will not be charged.
For those selecting the Open Access option, the charges for Schizophrenia Bulletin vary depending on the institution at which the corresponding author is based:
Optional Oxford Open charges:
For a corresponding author based at an institution with an online subscription to Schizophrenia Bulletin:
Regular charge - ?00 / $1800 / €1350
List B developing country charge** - ?50 / $900 / €675
List A developing country charge** - ? / $0 / €0
For a corresponding author based at an institution that does not subscribe to the online journal:
Regular charge - ?500 / $3000 / €2250
List B developing country charge** - ?50 / $1500 / €1125
List A developing country charge** - ? /$0 / €0
*Visit http://www.oxfordjournals.org/jnls/devel/ for list of qualifying countries.
The above Open Access charges are in addition to any page charges and color charges that might apply. Orders from the UK will be subject to a 17.5% VAT charge. For orders from elsewhere in the EU you or your institution should account for VAT by way of a reverse charge. Please provide us with your or your institution’s VAT number.
If you choose the Open Access option you will also be asked to complete an Open Access charge form online. You will be automatically directed to the appropriate version of the form depending on whether you are based at an institution with an online subscription to Schizophrenia Bulletin. Therefore please make sure that you are using an institutional computer when accessing the form. To check whether you are based at a subscribing institution please use the Subscriber Test link for Schizophrenia Bulletin.
Please see these guidelines for reuse of Oxford Open content.
PERMISSIONS FOR ILLUSTRATIONS AND FIGURES
Permission to reproduce copyright material, for print and online publication in perpetuity, must be cleared and if necessary paid for by the author; this includes applications and payments to DACS, ARS, and similar licensing agencies where appropriate. Evidence in writing that such permissions have been secured from the rights-holder must be made available to the editors. It is also the author's responsibility to include acknowledgements as stipulated by the particular institutions. Oxford Journals can offer information and documentation to assist authors in securing print and online permissions: please see the Guidelines for Authors section. Information on permissions contacts for a number of main galleries and museums can also be provided. Should you require copies of this, please contact the editorial office of the journal in question or the Oxford Journals Rights department.
Editorial Board
Editorial BoardEDITOR-IN-CHIEF
William T. Carpenter, Baltimore, MD
DEPUTY EDITO
Gunvant Thaker, Baltimore, MD
MANAGING EDITOR
Janet Smith, Baltimore, MD
FORMER EDITORS-IN-CHIEF
Loren Mosher
Samuel Keith
David Shore
John Hsiao
ASSOCIATE EDITORS
Lisa Dixon, Baltimore, MD
Susan M. Essock, New York, NY
Mark A. Geyer, La Jolla, CA
Philip D. Harvey, New York, NY
Daniel C. Javitt, New York, NY
Thomas H. McGlashan, New Haven, CT
Michael J. Owen, Cardiff, UK
Paul D. Shepard, Baltimore, MD
Jim van Os, Maastricht, Netherlands
EDITORIAL BOARD
Nancy C. Andreasen, Iowa City, IA
Paul S. Appelbaum, New York, NY
Celso Arango, Madrid Spain
Deanna M. Barch, St. Louis, MO
John J. Bartko, Newville, PA
David L. Braff, La Jolla, CA
Alan S. Brown, New York, NY
Tyrone Cannon, Los Angeles, CA
Arvid M. Carlsson, Gothenburg, Sweden
Cameron S. Carter, Sacramento, CA
Robert R. Conley, Baltimore, MD
Timothy J. Crow, Oxford, United Kingdom
Johan Cullberg, Stockholm, Sweden
Michael Davidson, Tel Aviv, Israel
John M. Davis, Chicago, IL
Ariel Deutch, Nashville, TN
Dwight Dickinson, Baltimore, MD
Robert E. Drake, Lebanon, NH
Wolfgang Fleischhacker, Innsbruck, Austria
Judith M. Ford, New Haven, CT
Robert Freedman, Denver, CO
Frederick J. Frese, Rootstown, OH
Donald Goff, Boston, MA
Anthony A. Grace, Pittsburgh, PA
Michael F. Green, Los Angeles, CA
Dilip V. Jeste, San Diego, California
Ren?S. Kahn, Utrecht, Netherlands
John M. Kane, Glen Oaks, NY
Shitij Kapur, Toronto, Canada
Richard Keefe, Durham, NC
Deanna Kelly, Baltimore, MD
Brian Kirkpatrick, Augusta, GA
Anthony F. Lehman, Baltimore, MD
David A. Lewis, Pittsburgh, PA
Jeffrey A. Lieberman, New York, NY
Dolores Malaspina, New York, NY
Anil K. Malhotra, Glen Oaks, NY
Steve R. Marder, Los Angeles, CA
Patrick D. McGorry, Victoria Australia
Kim T. Mueser, Concord, NH
Robin M. Murray, London, United Kingdom
Patricio O'Donnell, Baltimore, MD
Christos Pantelis, Melbourne, Australia
Godfrey D. Pearlson, Hartford, CT
Judith L. Rapoport, Bethesda, MD
Trevor W. Robbins, Cambridge, United Kingdom
Laura W. Roberts, Milwaukee, WI
Rosalinda C. Roberts, Birmingham, AL
Robert Rosenheck, West Haven, CT
Robert Schwarcz, Baltimore, MD
S. Charles Schulz, Minneapolis, MN
Larry J. Seidman, Boston, MA
John A. Sweeney, Chicago, IL
Carol A. Tamminga, Dallas, TX
Rajiv Tandon, Tallahassee, FL
Dawn I. Velligan, San Antonio, TX
Michael W. Vogel, Baltimore, MD
John L. Waddington, Dublin, Ireland
Daniel R. Weinberger, Bethesda, MD
Til Wykes, London, United Kingdom
Robert B. Zipursky, Toronto, Canada
|
刊名字顺( Alphabetical List of Journals):
返回页首 